Filing Details
- Accession Number:
- 0001209191-23-038753
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-21 16:05:15
- Reporting Period:
- 2023-06-16
- Accepted Time:
- 2023-06-21 16:05:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1654151 | Deciphera Pharmaceuticals Inc. | DCPH | Pharmaceutical Preparations (2834) | 200299725 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1713712 | Lee Daniel Flynn | C/O Deciphera Pharmaceuticals, Inc. 200 Smith Street Waltham MA 02451 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-06-16 | 1,655 | $14.40 | 57,158 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 180,947 | Indirect | By Daniel L. Flynn Revocable Trust |
Common Stock | 91,020 | Indirect | By Daniel L. Flynn Irrevocable Trust |
Common Stock | 49,488 | Indirect | By GRAT |
Footnotes
- This sale was to cover tax liabilities in the vesting of restricted stock units.
- Reflects shares previously transferred from the Daniel L. Flynn Revocable Trust to the Reporting Person's grantor retained annuity trust.